Börse:
48,650€
-1,17%
Echtzeit-Aktienkurs Anika Therapeutics
Bid:
48,455€
Ask:
48,845€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 691,32 Mio. EUR (14,21 Mio. x 48,650€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot 1 |
| dpa-AFX - | Reuters - |
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| KUV | 7,87 | 6,88 | 6,30 | 6,55 |
| KGV | 24,20 | 22,63 | 23,06 | 38,16 |
| Div. Rend. | - | - | - | - |
Echtzeit-Chart der Anika Therapeutics Aktie
Börsenkurse Anika Therapeutics
| Börse Stuttgart | 48,130€ | 0 | 49,205€ | 0 | 48,668€ | -0,48% |
| Lang & Schwarz | 48,455€ | 244 | 48,845€ | 244 | 48,650€ | -1,17% |
| Euro Indikation | 48,130€ | 0 | 49,205€ | 0 | 48,668€ | -0,86% |
| Dollar Indikation | 53,231$ | 0 | 54,267$ | 0 | 53,749$ | -1,05% |
Fundamentaldaten der Anika Therapeutics Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 105,56 Mio. | 23,21 Mio. | 18,72 Mio. | 1,28 | 0,00% | 38,16 | 6,55 |
| 2017 | 113,42 Mio. | 46,20 Mio. | 31,82 Mio. | 2,11 | 0,00% | 23,06 | 6,30 |
| 2016 | 103,38 Mio. | 50,87 Mio. | 32,55 Mio. | 2,15 | 0,00% | 22,63 | 6,88 |
| 2015 | 93,00 Mio. | 48,25 Mio. | 30,76 Mio. | 2,01 | 0,00% | 24,20 | 7,87 |
| 2014 | 105,60 Mio. | 61,51 Mio. | 38,32 Mio. | 2,51 | 0,00% | 19,38 | 6,84 |
| 2013 | 75,08 Mio. | 32,48 Mio. | 20,58 Mio. | 1,39 | 0,00% | 35,00 | 9,26 |
| 2012 | 71,36 Mio. | 19,53 Mio. | 11,76 Mio. | 0,82 | 0,00% | 59,33 | 9,45 |
| 2011 | 64,78 Mio. | 13,79 Mio. | 8,47 Mio. | 0,62 | 0,00% | 78,47 | 10,24 |
| 2010 | 55,56 Mio. | 7,34 Mio. | 4,32 Mio. | 0,32 | 0,00% | 152,03 | 11,81 |
| 2009 | 40,14 Mio. | 5,51 Mio. | 3,69 Mio. | 0,32 | 0,00% | 152,03 | 16,27 |
Profil der Anika Therapeutics Aktie
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration and wound healing. The company's products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen